The need for a vaccine from COVID-19 to a person is determined by the presence in the organism of antibodies to the disease. This was stated by the Deputy Director of the Central research Institute of epidemiology of Rospotrebnadzor for scientific work Alexander Gorelov in the program “Vesti Nedeli” on TV channel “Russia-1”.
“the antibody Titer or its absence will allow them to plan autumn vaccination against COVID-19. If you have high titer antibodies, you vaccination is not necessary”, – quotes the words of the scientist TASS.
In Russia, according to the Federal operative headquarters of the anti-coronavirus, for the first time since may 2 daily gain of infected was less than 10 thousand – 9 974 new cases.
In Russia stopped the growth of the spread of coronavirus
Recall, the Russian scientist-virologist, chief researcher at the National research center of epidemiology and Microbiology named after N. F. Gamalei, academician, full member of the Academy of natural Sciences Felix Ershov in the air NSN called the two companies, which in order of priority engaged in the development of the Russian vaccines: Novosibirsk “Vector” and “Pharmstandard”. The scientist also confirmed the risk-taking by Russian scientists test new vaccine against CОVID-19.
“the Vaccine is already on the way out, and I’m sure they (the developers – approx. NSN) experience it for yourself. Taken from virologists who are confident in the positive result of the development”, – said the expert.
the
